Myeloproliferative Disorders

Biology and Management
1. Auflage 2019
ISBN: 978-0-367-45291-9
Verlag: CRC Press

Buch, Englisch, 238 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 322 g

With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text myeloproliferative disorders gives the practicing clinician a single source answer to classification, diagnosis, management, and recent advances in this disorder.

Zielgruppe

Professional Reference

Autoren/Hrsg.

Silver, Richard T

Tefferi, Ayalew

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

Preface. Modern classification and diagnostic algorithms in myeloproliferative disorders. Diagnostic utility of bone marrow pathology in myeloproliferative disorders. Molecular pathogenesis of BCR/ABL-negative myeloproliferative disorders. Cytogenetic studies in myeloproliferative disorders. Congenital causes of erythrocytosis and thrombocytosis. Management of polycythemia vera. Management of essential thrombocythemia. Management of myelofibrosis with myeloid metaplasia. Contemporary diagnosis and management of systemic mastocytosis. Modern classification and treatment of primary eosinophilic disorders. Overlap MDS/MPD.

Über Autor(innen)

Richard T. Silver Ayalew Tefferi